125 related articles for article (PubMed ID: 12430252)
1. [Diabetic cardiomyopathy].
Terashima M; Goto Y
Nihon Rinsho; 2002 Oct; 60 Suppl 10():347-53. PubMed ID: 12430252
[No Abstract] [Full Text] [Related]
2. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
3. [Risk reduction of acute heart failure with initial administration of beta-blockers].
Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
[No Abstract] [Full Text] [Related]
4. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
Hayat SA; Patel B; Khattar RS; Malik RA
Clin Sci (Lond); 2004 Dec; 107(6):539-57. PubMed ID: 15341511
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
Guazzi M; Melzi G; Marenzi GC; Agostoni P
Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
[TBL] [Abstract][Full Text] [Related]
6. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure.
Tallaj JA; Franco V; Rayburn BK; Pinderski L; Benza RL; Pamboukian S; Foley B; Bourge RC
J Heart Lung Transplant; 2005 Dec; 24(12):2196-201. PubMed ID: 16364871
[TBL] [Abstract][Full Text] [Related]
7. How should we manage heart failure developing in patients already treated with angiotensin-converting enzyme inhibitors and beta-blockers for hypertension, diabetes or coronary disease?
Gustafsson F; Segura J; Ruilope LM
J Hypertens; 2010 Aug; 28(8):1595-8. PubMed ID: 20613629
[TBL] [Abstract][Full Text] [Related]
8. Unclassified cardiomyopathy in a geriatric cat.
Wolfson R
Can Vet J; 2005 Sep; 46(9):829-30. PubMed ID: 16231654
[TBL] [Abstract][Full Text] [Related]
9. [ACE-inhibitors and heart failure. Results of studies of left ventricular dysfunction].
Bornkessel B; Heinzl S
Med Monatsschr Pharm; 1992 Mar; 15(3):76-80. PubMed ID: 1569912
[No Abstract] [Full Text] [Related]
10. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
[TBL] [Abstract][Full Text] [Related]
11. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
Singh TP; Almond C
J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
[No Abstract] [Full Text] [Related]
12. [Diabetic cardiomyopathy: concept, heart function, and pathogenesis].
Codinach Huix P; Freixa Pamias R
An Med Interna; 2002 Jun; 19(6):313-20. PubMed ID: 12152393
[TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of congestive heart failure].
Liu P; Zhang X
Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):634-7. PubMed ID: 10436974
[No Abstract] [Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
Thornton PL; Ahmed A
J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
[No Abstract] [Full Text] [Related]
15. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
16. Management of a case of peripartum cardiomyopathy.
Baughman KL
Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):514-8; quiz 518. PubMed ID: 16932769
[TBL] [Abstract][Full Text] [Related]
17. [Restrictive cardiomyopathy associated with heart failure].
Konno T; Ino H; Fujino N; Hayashi K; Yamagishi M
Nihon Rinsho; 2007 May; 65 Suppl 5():430-7. PubMed ID: 17571415
[No Abstract] [Full Text] [Related]
18. Pharmacological treatment and prevention of heart failure in the diabetic patient.
Nesto RW
Rev Cardiovasc Med; 2004; 5(1):1-8. PubMed ID: 15029109
[TBL] [Abstract][Full Text] [Related]
19. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
[No Abstract] [Full Text] [Related]
20. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
Porcu M
Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
